Research and education

Approximately one in every five adults1 have sleep-disordered breathing (SDB).

An expanding body of scientific evidence clearly indicates that SDB has a profound negative impact on public health.

Through its strong partnership with the global medical community, ResMed is committed to:

  • increasing awareness of the dangers of untreated SDB
  • supporting ongoing research into the correlation of SDB with other health risks
  • finding effective clinical solutions to improve the health and lives of SDB patients

Noninvasive ventilation for COPD patients

Read a selection of research articles on the topics of bilevel therapy and noninvasive ventilation.

AutoSet technology

Learn more about the differences between fixed pressure and auto-adjusting therapy devices.

ResMed Academy Online

The ResMed Academy Online is designed to provide you with easy access to a variety of learning resources at no cost.

ResMed Academy Online

ResMed Academy Online

The ResMed Academy Online is designed to provide you with easy access to a variety of learning resources at no cost.

Diabetes and sleep apnoea

Explore research about diabetes in relation to sleep and respiratory care.

Sleep apnoea and cardiovascular issues

Further explore research topics on cardiovascular disease and its connection to sleep apnoea and SDB.

Obesity and sleep apnoea

Read about obesity research in relation to sleep-disordered breathing and respiratory care.

Farrell favorites

ResMed Founder and Chairman Dr. Peter Farrell identifies key research findings that are shaping the field of sleep medicine today.

ResMed Support for Investigator-Initiated Research

ResMed Support for Investigator-Initiated Research

As part of our commitment to deliver innovative therapies to patients across the globe, ResMed believes in the need to support ethical, independent clinical research, conducted by qualified third-party investigators.